Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib

被引：0
|
作者：
Shunsuke Maruta
Kyohei Usami
Kazuko Tajiri
Masafumi Otani
Daigo Hiraya
Hiroaki Watabe
Tomoya Hoshi
Akira Sato
Masaki Ieda
机构：
[1] University of Tsukuba,Department of Cardiology, Faculty of Medicine
来源：
Cardio-Oncology | / 7卷
关键词：
Chronic myeloid leukemia; Coronary angiography; Coronary circulation; Coronary spasm; Vasospastic angina; Tyrosine kinase inhibitor; Cardio-oncology; Onco-cardiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pemphigus foliaceous-like reaction in a patient with chronic myeloid leukemia treated with the tyrosine kinase inhibitors nilotinib and dasatinib
    Nuno-Gonzalez, Almudena
    Dehesa, Luis
    Ricotti, Carlos
    Kerdel, Francisco
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (04) : 494 - 496
  • [22] The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia
    Minson, Adrian G.
    Cummins, Katherine
    Fox, Lucy
    Costello, Ben
    Yeung, David
    Cleary, Rebecca
    Forsyth, Cecily
    Tatarczuch, Maciek
    Burbury, Kate
    Motorna, Olga
    Shortt, Jake
    Fleming, Shaun
    McQuillan, Andrew
    Schwarer, Anthony
    Harrup, Rosemary
    Holmes, Amy
    Ratnasingam, Sumita
    Chan, Kah-Lok
    Hsu, Wei-Hsun
    Ashraf, Asma
    Putt, Faye
    Grigg, Andrew
    BLOOD ADVANCES, 2019, 3 (07) : 1084 - 1091
  • [23] Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib
    Martino, Bruno
    Mammi, Corrado
    Labate, Claudia
    Rodi, Silvia
    Ielo, Domenica
    Priolo, Manuela
    Postorino, Maurizio
    Tripepi, Giovanni
    Ronco, Francesca
    Lagana, Carmelo
    Musolino, Caterina
    Greco, Marianna
    La Nasa, Giorgio
    Caocci, Giovanni
    EXPERIMENTAL HEMATOLOGY, 2017, 55 : 71 - 75
  • [24] Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
    Kim, T. D.
    Rea, D.
    Schwarz, M.
    Grille, P.
    Nicolini, F. E.
    Rosti, G.
    Levato, L.
    Giles, F. J.
    Dombret, H.
    Mirault, T.
    Labussiere, H.
    Lindhorst, R.
    Haverkamp, W.
    Buschmann, I.
    Doerken, B.
    le Coutre, P. D.
    LEUKEMIA, 2013, 27 (06) : 1316 - 1321
  • [25] Nilotinib therapy in an imatinib intolerant chronic myeloid leukemia patient with pulmonary severe hypertension
    Annunziata, Mario
    CLINICAL MANAGEMENT ISSUES, 2010, 4 : 17 - 20
  • [26] Thyroid dysfunction in chronic myeloid leukemia patients on nilotinib
    Khaleel, Khaleed J.
    Matloob, Ahmed H.
    Hatim, Abdalsalam
    IRAQI JOURNAL OF HEMATOLOGY, 2018, 7 (01) : 33 - 38
  • [27] DYNAMICS OF CHRONIC MYELOID LEUKEMIA UNDER NILOTINIB THERAPY
    Dingli, O.
    Lenaerts, T.
    Castagnetti, F.
    Traulsen, A.
    Pacheco, J.
    Rosti, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 347 - 348
  • [28] Successful Nilotinib Treatment in a Child with Chronic Myeloid Leukemia
    Al-Jafar, Hassan A.
    Al-Mulla, Ali
    AlDallal, Salma
    Buhamad, Jaber H.
    Askar, Haifa
    CASE REPORTS IN ONCOLOGY, 2015, 8 (01): : 121 - 126
  • [29] FUNCTIONAL CHARACTERISTICS OF ERYTHROID PROGENITOR CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB AND NILOTINIB
    Perekhrestenko, T.
    Sviezhentseva, I.
    Bilko, D.
    Tretiiak, N.
    Dyagil, I.
    HAEMATOLOGICA, 2017, 102 : 725 - 725
  • [30] Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure
    Palandri, Francesca
    Castagnetti, Fausto
    Soverini, Simona
    Poerio, Angela
    Gugliotta, Gabriele
    Luatti, Simona
    Amabile, Marilina
    Martinelli, Giovanni
    Rosti, Gianantonio
    Baccarani, Michele
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1758 - 1761
12345